Pictet Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.9M | Buy |
1,699,944
+290,745
| +21% | +$10.6M | 0.06% | 284 |
|
|
2025
Q1 | $52M | Buy |
1,409,199
+235,561
| +20% | +$8.69M | 0.06% | 298 |
|
|
2024
Q4 | $49.4M | Buy |
1,173,638
+653,088
| +125% | +$27.5M | 0.05% | 301 |
|
|
2024
Q3 | $28.3M | Sell |
520,550
-36,268
| -7% | -$1.97M | 0.03% | 403 |
|
|
2024
Q2 | $22.9M | Sell |
556,818
-479,556
| -46% | -$19.7M | 0.03% | 436 |
|
|
2024
Q1 | $48.5M | Buy |
1,036,374
+13,238
| +1% | +$619K | 0.05% | 313 |
|
|
2023
Q4 | $48.9M | Buy |
1,023,136
+153,748
| +18% | +$7.35M | 0.05% | 316 |
|
|
2023
Q3 | $31M | Buy |
+869,388
| New | +$31M | 0.04% | 362 |
|